Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Prevalence in the USA of rilpivirine resistance-associated mutations in clinical samples and effects on phenotypic susceptibility to rilpivirine and etravirine

(2014) Gaston R Picchio et al.   ANTIVIRAL THERAPY

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013

(2014) Joanne D Stekler et al.   ANTIVIRAL THERAPY

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

(2014) Dineke Frentz et al.   BMC INFECTIOUS DISEASES

Antiretroviral Treatment of Adult HIV Infection

(2014) Huldrych F. Günthard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification

(2014) Daniel Struck et al.   NUCLEIC ACIDS RESEARCH

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group

(2014) Dineke Frentz et al.   PLoS One

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

(2013) Hong-Tao Xu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

96-week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE Phase III trials

(2013) Laurence Rimsky et al.   ANTIVIRAL THERAPY

The HIVdb System for HIV-1 Genotypic Resistance Interpretation

(2012) Michele W. Tang et al.   INTERVIROLOGY

Transmitted Drug Resistance and Phylogenetic Relationships Among Acute and Early HIV-1–Infected Individuals in New York City

(2012) Delivette Castor et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09

(2012) A. N. Burchell et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

(2012) Ravindra K Gupta et al.   LANCET

Integrase and Fusion Inhibitors Transmitted Drug Resistance in Naive Patients With Recent Diagnosis of HIV-1 Infection

(2011) Francesca Cossarini et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

(2011) Jean-Michel Molina et al.   LANCET

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

(2011) Linda Wittkop et al.   LANCET INFECTIOUS DISEASES

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

(2009)   AIDS

Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe

(2009) Jurgen Vercauteren et al.   JOURNAL OF INFECTIOUS DISEASES

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects

(2008) Daniel R. Kuritzkes et al.   JOURNAL OF INFECTIOUS DISEASES

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

(2008) S. J. Little et al.   JOURNAL OF VIROLOGY